Article

jdsupra.comjdsupra.com on 2020-09-14 19:20

EMA Recommends Blenrep, Adakveo, and Equidacent for Approval; Recommends Change in Prescription Status for Crysvita and Imfinzi

During the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) meeting this July, the CHMP recommended the approval of two biologics and one ...

Related news